Unicycive Therapeutics, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Unicycive Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2021 to Q2 2024.
  • Unicycive Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was 0.08 USD/shares.
  • Unicycive Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -0.55 USD/shares, a 72.2% increase year-over-year.
  • Unicycive Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1.28 USD/shares, a 6.67% decline from 2022.
  • Unicycive Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -1.2 USD/shares, a 39.5% decline from 2021.
  • Unicycive Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -0.86 USD/shares, a 219% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$1 $0.08 +$0.37 Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$1 -$1 +$0.36 +37.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$1 $0.11 +$0.46 Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$2 $0 +$0.24 +64.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$2 $0 $0 -20.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$2 -$1 -$1 -304% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$1 $0 $0 -40% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$1 $0 $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$1 $0 $0 -84.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$1 $0 $0 -118% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-16
Q4 2021 -$1 $0 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.